Association between Diet Quality and Risk of Type 2 Diabetes Mellitus in Patients with Coronary Heart Disease: Findings from the CORDIOPREV Study.

Autor: Rivas-Garcia L; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain., Quintana-Navarro GM; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain., Alcala-Díaz JF; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain., Torres-Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain., Arenas-de Larriva AP; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain., Rangel-Zuñiga OA; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., López-Moreno A; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Malagon MM; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, 14004 Córdoba, Spain., Katsiki N; Department of Nutritional Sciences and Dietetics, International Hellenic University, 57400 Thessaloniki, Greece.; School of Medicine, European University Cyprus, Nicosia 2404, Cyprus., Perez-Martinez P; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain., Lopez-Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain., Delgado-Lista J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, 14004 Córdoba, Spain.; Maimónides Biomedical Research Institute of Córdoba (IMIBIC), 14004 Córdoba, Spain.; CIBER Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Medical and Surgical Sciences, University of Córdoba, 14004 Córdoba, Spain.
Jazyk: angličtina
Zdroj: Nutrients [Nutrients] 2024 Apr 22; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 22.
DOI: 10.3390/nu16081249
Abstrakt: The incidence of type 2 diabetes mellitus (T2DM) is growing in Western countries. Nutritional interventions that promote high-quality dietary patterns could help reverse this trend. We aimed to evaluate whether changes in Nutrient-Rich Food Index 9.3 (NRF9.3) were related to the risk of developing T2DM in patients with coronary heart disease (CHD). The study was carried out in the context of two healthy dietary interventions (a Mediterranean and a low-fat diet). For this purpose, we evaluated all the patients in the CORDIOPREV study without T2DM at baseline. Data were obtained during the first 5 years of dietary intervention. The score was calculated using the Food Frequency Questionnaires at baseline and after 1 year of intervention. After 5 years of follow-up, 106 patients developed T2DM (incident-T2DM), while 316 subjects did not (non-T2DM). Total NRF9.3 score and changes during the first year of intervention were compared between incident-T2DM and non-T2DM. Incident-T2DM showed less improvement in NRF9.3 than non-T2DM ( p = 0.010). In the multi-adjusted Cox proportional hazard study, patients with greater improvement in NRF9.3 had over 50% less risk of developing T2DM compared with the lowest tertile (HR 2.10, 95%, CI = 1.12-3.56). In conclusion, improved diet quality in terms of nutrient density after the dietary intervention was associated with a lower risk of T2DM in patients with CHD.
Databáze: MEDLINE
Externí odkaz: